Plant-based clinical nutrition company, Kate Farms, has raised $75 million in a Series C funding round.

Kate Farms produces organic and vegan-friendly formulas for tube and oral feeding to meet the nutritional needs of those with chronic illnesses and acute conditions.

Led by life science investor Novo Holdings, the round also received participation from existing investors, and is for a minority stake in the company.

“Novo Holdings’ investment in Kate Farms will allow us to develop more innovative products, enter new markets and continue to serve the patients who depend on us for their nutrition, as well as thousands of healthcare providers,” said Kate Farms chairman and CEO, Brett Matthews.

Kartik Dharmadhikari, partner, Novo Growth, Novo Holdings, added: “We are pleased to partner with Kate Farms and support them in their efforts to meet the nutritional needs of numerous patient populations”.

“We believe our life sciences heritage can serve the company well as it explores additional ways to utilise science and clinical evidence to support plant-based clinical nutrition.”

#clinicalnutrition #KateFarms #US